Thomas Pocklington Trust and Sight Loss Councils ‘Cut it back’ campaign
TPT and Sight Loss Councils: Cut it back campaign
Search results
TPT and Sight Loss Councils: Cut it back campaign
Inflammation and retinal degeneration in retinitis pigmentosa: Can lessons learned in the lab help us identify treatments in the clinic?
Colin McArthur re-joined the board in 2024 after serving as a trustee between January 2008 and September 2019.
Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.
Whether you are looking for practical information or emotional support, online, by phone or face-to-face, we’re here to help.
Thursday 27 February, 12.00pm - In-person - Please come and join us for a social catch up over lunch at The White Hart pub in Aylesbury town centre.
Have you ever been tempted to take part in the TCS London Marathon? In 2022 the TCS London Marathon raised £58.3 million for charity so it’s a vital source of income.
Martin's son was diagnosed with Stargardt’s at a young age which has led Martin to take a close interest in the progress of research into Retinal disease.